SCHEMBL7433950

SCHEMBL7433950

CC(C)CC(Nc1nc(-c2cccc(NC(=O)Nc3ccccc3)c2)cs1)C(=O)O

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 11/20 0.58
ADORA3 P0DMS8 1/20 0.58
MEN1 O00255 9/20 0.58
KMT2A Q03164 9/20 0.58
SMN1; SMN2 Q16637 7/20 0.55
HTT P42858 3/20 0.55
KDM4E B2RXH2 2/20 0.55
NPC1 O15118 2/20 0.53
RAB9A P51151 2/20 0.53
GAA P10253 1/20 0.53
NPSR1 Q6W5P4 1/20 0.53
TP53 P04637 1/20 0.53
ALDH1A1 P00352 5/20 0.52
ROCK1 Q13464 1/20 0.52
LMNA P02545 4/20 0.52
MAPK1 P28482 3/20 0.52
BAZ1A Q9NRL2 1/20 0.52
NFKB1 P19838 1/20 0.48
NFKB2 Q00653 1/20 0.48
RELA Q04206 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7433934 1.00 MAPT (0.58) MAPTADORA3MEN1KMT2ASMN1; SMN2
SCHEMBL6185021 0.88 MEN1 (0.52) MAPTADORA3MEN1KMT2ASMN1; SMN2
SCHEMBL6181829 0.82 MEN1 (0.52) MAPTADORA3MEN1KMT2ASMN1; SMN2
SCHEMBL6180437 0.81 ROCK2 (0.50) MAPTMEN1KMT2ASMN1; SMN2HTT
SCHEMBL7439002 0.79 ROCK2 (0.50) MAPTMEN1KMT2ASMN1; SMN2HTT
SCHEMBL8823169 0.75 MAPT (1.00) MAPTADORA3MEN1KMT2ASMN1; SMN2
SCHEMBL5869395 0.72 MEN1 (0.60) MAPTMEN1KMT2ASMN1; SMN2NPC1
SCHEMBL5869382 0.72 MEN1 (0.60) MAPTMEN1KMT2ASMN1; SMN2NPC1
SCHEMBL6180116 0.72 CTSK (0.56) MEN1KMT2A
SCHEMBL5869368 0.72 MEN1 (0.60) MAPTMEN1KMT2ASMN1; SMN2NPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2001068645-A2 N-CYANOMETHYLCARBOXAMIDES AND THEIR USE AS PROTEASE INHIBITORS AXYS PHARMACEUTICALS, INC. (US) 2001-09-20 WO disclosed